Introduction {#s1}
============

Norovirus (NoV) is a non-enveloped single-strand positive-sense RNA virus, with a 7.5 kb genome that is divided into three open reading frames (ORFs). ORF1 encodes a large polyprotein that includes the viral RNA-dependent RNA polymerase, and ORF2 and ORF3 encode the major (VP1) and minor (VP2) capsid proteins, respectively \[[@r6], [@r51], [@r53]\]. A novel open reading frame overlapping ORF2, designated ORF4, is only present in murine NoV (MNV), and encodes the protein virulence factor 1 (VF1) \[[@r27]\].

NoV is a member of *Caliciviridae* family, which is classified into six genogroups (G) according to their capsid gene sequence \[[@r53]\]. Human NoV (HuNoV) belongs to the groups GI, GII, and GIV \[[@r5], [@r6]\], porcine NoV belongs to GII genogroup, and bovine NoV belongs to GIII \[[@r32], [@r42]\]. The feline and canine NoVs are members of the GIV and GVI genogroups, respectively \[[@r26], [@r49]\], while MNV belongs to GV \[[@r15]\].

Currently, HuNoV is a significant viral agent that is able to cause acute gastroenteritis in people of all ages \[[@r37], [@r39]\]. However, even though HuNoV is recognized as a worldwide pathogen \[[@r1], [@r2], [@r8], [@r12], [@r16], [@r22], [@r50]\], the establishment of *in vitro* propagation methods have thus far been unsuccessful \[[@r23], [@r43]\], although recent progress in the cultivation of HuNoV has been described \[[@r13], [@r14]\]. Additionally, the prototype murine NoV strain, MNV-1, has been used as a model to better understand the molecular mechanisms and pathogenicity of NoVs \[[@r45], [@r52]\].

MNV was first described by Karst *et al.* in 2003, in a strain of laboratory mice that was both RAG2^−/−^ (recombination activating gene 2) and STAT1^−/−^ (signal transducer and activator of transcription 1) \[[@r15]\]. MNV is a highly prevalent laboratory mouse pathogen \[[@r11], [@r17], [@r31], [@r38], [@r40]\] that can cause persistent infection in many different mouse strains \[[@r10]\].

Taken advantage of the fact that NoV can infect a broad range of hosts, several studies have been done to identify and characterize NoV in laboratory rats. In 2012, Smith *et al.* were unable to detect MNV related viruses in different rodent species using a molecular and multiple degenerate primers \[[@r41]\]. In attempt to demonstrate infection of rats with NoV, other researchers used serological tests as dot blot assays, multiplexed fluorometric immunoassays (MFIA), and indirect immunofluorescence assays (IFA) to investigate the presence of MNV antigens in a colony of Sprague-Dawley rats. Although the serological tests had been performed, the molecular characterization and virus isolation methods were unsuccessful \[[@r11]\].

The infection of rat strains with NoV was initially reported by Japanese researchers, who demonstrated the NoV infection of wild rodents belonging to the species *Rattus rattus and Apodemus speciosus* \[[@r48]\]. Phylogenetic analysis of the NoV nucleotide sequences in this case showed that different viruses infected two wild rodent species, suggesting that the genetic diversity of NoV is associated with host species and geographic distribution \[[@r41]\]. The complete genome sequences of two novel NoVs, JX486101 and JX486102, isolated from brown rats (*Rattus norvergicus*), were subsequently deposited in GenBank \[[@r47]\]. These two sequences were shown to have 91.4% identity and were approximately 7541 bases in length. This report confirmed that the organization of the rat NoV genome is similar to that of other NoV.

In this way, the current study aimed to develop a sensitive semi-nested RT-PCR assay for detection of NoV in fecal samples from laboratory rats (*Rattus norvegicus*) in Brazilian animal facilities.

Material and Methods {#s2}
====================

Ethics statement
----------------

This study was carried out in strict accordance with the recommendations of National Council on Animal Experimentation (CONCEA) from Science and Technology Ministry (MCTI) from Brazil. The protocol was approved by the Institutional Animal Care and Use Committee of the University of Campinas (CEUA - UNICAMP), under the protocol number 2901-1.

Fecal samples
-------------

One hundred and eight fecal samples from laboratory rats, from 23 Brazilian animal facilities, were collected in the Laboratory of Animal Health at the Multidisciplinary Center for Biological Research on Laboratory Animal Science (CEMIB). Fecal samples were tested for the presence of NoV as part of a health monitoring program. Seventeen of the 23 facilities kept laboratory rats under conventional conditions, while the other 6 facilities maintained rats in specific pathogen-free (SPF) barrier conditions. Four wild rat fecal samples were also obtained and included in the study.

Prior to nucleic acid extraction, a 20% (w/v) fecal suspension was prepared. Feces were weighed, dissolved in 0.01 M PBS (pH 7.2), and centrifuged at 6,000 g for 10 min. The supernatant was collected and stored at −80°C until use.

RNA extraction
--------------

RNA was extracted from the previous prepared 20% fecal suspension using a QIamp Viral RNA mini kit (QIAgen^®^ Inc., Valencia, California) according to the manufacturer's instructions, and stored at −80°C until use.

Primer design
-------------

Primer sequences that were complementary to the highly conserved region of the capsid gene (VP1) were designed, using an alignment of the sequences from MNV-1 (GenBank accession: AY228235) \[[@r11]\] and rat NoV (JX486101 and JX486102\*\*) \[[@r47]\]. Primer pairs are summarized in [Table 1](#tbl_001){ref-type="table"}Table 1.RT-PCR and semi-nested PCR primer sequencesPrimerSequence (5' - 3')Position\*\*Amplicon sizeFirst ReactionForward AAATTTTGTCCAGTG\*YCCCCTT5271--5292199bpReverse AACCACCTTGCCAGCAGTAA5469--5450Semi-Nested PCRForward TTCACCGTCTCCCCAAGAA5299--5317171bpReverse AACCACCTTGCCAGCAGTAA5469--5450IUB code: \*Y=C or T \*\*(JX486101 and JX486102).

Reverse transcription PCR (RT-PCR) and semi-nested PCR
------------------------------------------------------

RT-PCR was performed using a OneStep RT-PCR Kit (QIAgen^®^ Inc., Valencia, California) according to the manufacturer's recommended protocol. Each 25 *µ*l reaction volume included: 0.2 *µ*M of each primer, 1× OneStep RT-PCR buffer, 0.4 mM of dNTPs, 10 U/*µ*l of RNase Inhibitor, 1× Q-solution buffer, and 1 *µ*l of enzyme mix. The cycling conditions were as follow: 50°C for 30 min; DNA polymerase activation at 96°C for 2 min; 40 cycles of amplification, with an initial denaturation at 95°C for 30 s, primer annealing at 55°C for 30 s, and primer extension at 72°C for 1 min.

The product of the first reaction was used as template in the semi-nested PCR reaction, which was performed using the PCR conditions described above. All the reactions were performed in a GenePro 96G thermal cycler (Hangzhou Bori Technology Co., Ltd., BioER). The PCR amplicons were analyzed by agarose gel electrophoresis, stained with GelRed^TM^ nucleic acid stain (Uniscience, Hayward-CA), and visualized using a Geldoc-It^TM^ imaging system (UVP, Cambridge).

Cloning and sequencing
----------------------

The amplified products were cloned into a pGEM^®^-T Easy Vector System (Promega Corporation, Madison-USA). The cloned products were purified, and sequenced in both directions with semi-nested primers by capillary electrophoresis using BigDye^®^ Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA), and an ABI 3500 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Sequence analysis was performed using Sequencing Analysis Software v5.4 (Applied Biosystems, Foster City, CA, USA).

Sequence analysis
-----------------

The sequencing chromatograms were visualized using the BioEdit sequence alignment editor program version 7.2.5, \[[@r7]\] and the sequences were analyzed in the NCBI Entrez Nucleotide browser (www.ncbi.nlm.nih.gov/sites/entrez). A consensus sequence was created and assembled using the CodonCode Aligner software (CodonCode Corporation, Dedham, MA, USA). The amplicons obtained in this study were aligned using the ClustalW algorithm within the BioEdit software (1,000 bootstrap replicates) and compared with the reference nucleotide sequences from GenBank that are listed in [Table 2](#tbl_002){ref-type="table"}Table 2.Reference norovirus sequences used in this studyPrototype strainsAccession No (GenBank)Genogroup/ speciesRn/GV/HKU_CT2/HKG/2011JX486101RatRn/GV/HKU_KT/HKG/2012JX486102RatHu/GI.1/CHA6A003_20091104/2009/USAKF039737GI (Human)Swine/GII/OH-QW125/03/USAY823305GII (Swine)Hu/NLV/GII/Neustrelitz260/2000/DEAY772730GII (Human)Bo/Newbury2/1976/UKAF097917GIII (Bovine)cat/GIV.2/CU081210E/USA/2010JF781268GIV (Feline)Hu/GIV.1/LakeMacquarie/NSW268O/2010/AUJQ613567GIV (Human)Mu/NoV/GV/MNV1/2002/USAAY228235GV (Murine)Murine norovirus 2 (MNV-2)DQ223041GV (Murine)Murine norovirus 3 (MNV-3)DQ223042GV (Murine)Murine norovirus 4 (MNV-4)DQ223043GV (Murine)Murine norovirus 5 (MNV-5)EF650480GV (Murine)Murine norovirus 6 (MNV-6)EF650481GV (Murine)Murine norovirus 7 (MNV-7)GQ180108GV (Murine)MNV/Brasilia-DF/Pr+Ob/2012KF976714GV (Murine)Murine norovirus strain TF3PLM capsid protein VP1JQ408727GV (Murine)Murine norovirus strain TF7WM capsid protein VP1JQ408738*Apodemus agrarius*Murine norovirus isolate Mu/NoV/Apo455/UK/2007JN975491*Apodemus sylvaticus*dog/GVI.1/HKU_Ca035F/2007/HKGFJ692501GVI (Canine)Norwalk virusM87661Outgroup.

Results {#s3}
=======

Using conventional RT-PCR, no positive results were obtained, even with specific primers. A semi-nested RT-PCR protocol, producing an amplicon 171 bp in length, was therefore established. Twelve of the 108 fecal samples (11%), obtained from 6 different animal facilities (33% SPF and 67% conventional) were NoV positive by semi-nested PCR ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Detection of Rat NoV in fecal samples by semi-nested RT-PCR. A 2% agarose gel was stained with GelRed™. The 171 bp amplicons from semi-nested RT-PCR are shown. MW 50 bp. Lanes 1--11: amplified products from 11 rat fecal samples. Lane 12: negative control (DEPC-treated water). Lane 13: positive control (plasmid).). Furthermore, all of the wild rat samples were negative for NoV.

All the NoV-positive amplicons were sequenced and given the unique identifiers LCQS Unib1 through 12. Molecular analysis of these amplicons revealed 98% nucleotide identity with two prototype strains of rat NoV (JX486101 and JX486102) and presented higher identity, 38--82% with GV prototypes. In the other NoV genogroups the identity values ranged between 3% and 31%, as shown in the identity matrix ([table 3](#tbl_003){ref-type="table"}Table 3.Identity matrixGenogroupSeq-\>Rat\
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Unib12Rat LCQS Unib1\*100%100%98%56%89%100%100%99%99%93%95%Rat LCQS Unib2100%\*100%98%56%89%100%100%99%99%93%95%Rat LCQS Unib3100%100%\*98%56%89%100%100%99%99%93%95%Rat LCQS Unib498%98%98%\*56%91%98%98%98%98%92%94%Rat LCQS Unib556%56%56%56%\*48%56%56%56%56%52%57%Rat LCQS Unib689%89%89%91%48%\*89%89%88%89%84%85%Rat LCQS Unib7100%100%100%98%56%89%\*100%99%99%93%95%Rat LCQS Unib8100%100%100%98%56%89%100%\*99%99%93%95%Rat LCQS Unib999%99%99%98%56%88%99%99%\*98%93%95%Rat LCQS Unib1099%99%99%98%56%89%99%99%98%\*93%95%Rat LCQS Unib1193%93%93%92%52%84%93%93%93%93%\*89%Rat LCQS Unib1295%95%95%94%57%85%95%95%95%95%89%\*Rat NoVJX48610196%96%96%98%54%88%96%96%95%95%90%92%Rat NoVJX48610297%97%97%98%55%89%97%97%96%96%90%92%GI (Human)KF0397376%6%6%5%3%5%6%6%6%6%5%5%GII (Human)AY7727305%5%5%5%3%5%5%5%5%5%5%5%GII (Swine)AY8233055%5%5%5%3%5%5%5%5%5%5%5%GIII (Bovine)AF09791731%31%31%30%17%29%31%31%30%30%29%29%GIV (Feline)JF7812685%5%5%5%3%5%5%5%5%5%4%4%GIV Human)JQ6135675%5%5%5%3%5%5%5%5%5%5%5%GV (Murine)AY22823575%75%75%77%44%69%75%75%75%75%69%72%GV (Murine)DQ22304177%77%77%78%48%71%77%77%77%76%70%75%GV (Murine)DQ22304263%63%63%64%38%62%63%63%63%62%58%61%GV (Murine)DQ22304376%76%76%77%46%71%76%76%76%75%69%74%GV (Murine)EF65048077%77%77%77%48%71%77%77%77%77%71%76%GV (Murine)EF65048177%77%77%77%48%71%77%77%77%77%71%76%GV (Murine)GQ18010879%79%79%79%47%72%79%79%79%78%72%77%GV (Murine)KF97671478%78%78%78%47%71%78%78%78%77%72%76%GV (Murine)JQ40872780%80%80%82%45%75%80%80%80%80%74%76%GVI (Canine)FJ6925015%5%5%5%3%5%5%5%5%5%5%5%*A. Sylvaticus*JN97549167%67%67%68%40%66%67%67%67%66%61%65%*A. agrarius*JQ40873877%77%77%78%46%71%77%77%77%76%70%75%outgroupM876616%6%6%5%3%5%6%6%6%5%5%5%\*100% identity).

The VP1 capsid sequences for all the prototype strains and our amplicons were aligned, and two single base substitutions were revealed in all 12 amplicons. These two substitutions, at positions 5334 (C to T) and 5343 (T to C) did not however represent a structural change in the protein.

A phylogenetic tree was constructed using a member of the *Caliciviridae* family, Norwalk virus (M87661), as outgroup. In constructing the phylogenetic tree the neighbor-joining method (1,000 replicates) was applied in the Molecular Evolutionary Genetic Analysis (MEGA 6) software package \[[@r44]\], with settings to account for nucleotide substitution rates and the pairwise deletion of gaps ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Phylogenetic tree of NoV. The tree was constructed using 132 nt of the capsid protein VP1 sequences from genogroups GI to GVI and the amplicons Rat LCQS Unib1 to 12. The phylogenetic tree was generated using neighbor joining method in the MEGA 6.06 software package with bootstrap analysis (1,000 replicates). Norwalk virus (M87661) were used as outgroup.).

Discussion {#s4}
==========

Methods for detection NoV have been developed, and are well-established in laboratories of animal health monitoring \[[@r3], [@r4], [@r36]\]. MNV has been described as the most prevalent viral agent in mice colonies \[[@r10], [@r11], [@r17], [@r20], [@r21], [@r25], [@r40]\], and NoV infection of laboratory animals has been diagnosed using RT-PCR \[[@r11], [@r28]\], qRT-PCR \[[@r9]\], enzyme-linked immunosorbent assay (ELISA) \[[@r17], [@r18]\] and multiplexed fluorescent immunoassay \[[@r11]\]. Currently, nested and semi-nested PCR is the most sensitive diagnostic assay for the detection of low concentrations of RNA virus, and is mainly used for stool and environmental samples \[[@r19]\]. In this study, we have developed a semi-nested RT-PCR protocol for the detection of NoV in fecal samples from laboratory rats.

Although we used specific primers, we obtained a low sensitivity of detection for NoV, probably because of the low concentration of viral RNA in our samples. Conversely, using the semi-nested RT-PCR method, we found that 12 of the 108 fecal samples contained NoV, a positivity rate of 11%. All of the positive samples came from Brazilian animal facilities that kept animals either under a sanitary protection barrier system or in conventional environmental conditions. These results indicate that NoV is circulating in rat facilities, and that it can infect animals that are maintained in different sanitary conditions.

In the first report about the occurrence of MNV-like virus in wild rodents, Tsunesumi *et al.* found a 14.9% positivity rate from 47 analyzed fecal samples \[[@r48]\]. Conversely, we were unable to detect NoV in wild rat samples, which could be the result of either the geographic localization and distribution of these animals in Brazil, or the small sample size used here as already related by other researchers \[[@r41]\].

Molecular analysis of the sequences these amplicons were also compared with those from the prototype strains from each of the NoV genogroups (GI-GVI), and in all twelve cases single base substitutions from either C to T, or T to C, were observed between our amplicons and rat NoV references. While these base changes were not predicted to lead to amino acid substitutions, these polymorphisms probably describe the independent evolution of NoV strains \[[@r30]\]. The recombination of single-stranded RNA viruses, allowing the emergence of new viral strains, is known to occur often in the *Caliciviridae* family \[[@r29]\]. Furthermore, due to the high frequency of recombination at the ORF1-ORF2 junction in VP1 capsid protein or RNA-dependent RNA polymerase NoV sequences, several researchers recommend the phylogenetic analysis of the complete NoV genome \[[@r29], [@r46]\].

However, in this study, a phylogenetic analysis was performed based on an alignment of the NoV VP1 sequences. It allowed us to cluster all of the amplicons obtained from the rat samples within a subgroup of genogroup V. Consistent with previous reports \[[@r47], [@r48], [@r51]\], we suggest that rat NoV comprises a new cluster within genogroup V.

This is the first report of the development of a semi-nested RT-PCR assay for the identification of NoV in laboratory rats (*Rattus norvegicus*) in Brazil, and the first evidence of the prevalence of this viral agent in Brazilian animal facilities. Previously, rat NoV had only been described in *Rattus rattus* and *Apodemus speciosus* \[[@r48]\].

At the present time, it is not clear what impact the presence of NoV has on rat colonies, and further studies are required to better understand both the pathogenesis of NoV and its impact on research using rat models.

As already described, laboratory mouse colonies have also a high prevalence of MNV \[[@r10], [@r11], [@r17], [@r20], [@r21], [@r25], [@r40]\]. A previous report of our workgroup has demonstrated that most of the Brazilian animal facilities are dealing with MNV-infected mice \[[@r40]\].

Since it has an impact on the experimental results \[[@r33],[@r34],[@r35]\] is primordial a regular health monitoring program for this agent. FELASA (Federation for Laboratory Animal Science) has recommended a routine screening for most of the commons mouse and rat infectious agents \[[@r24]\]. Rat NoV is not yet been included in FELASA list and based in our results we strongly recommend that rat NoV should be included in this list and also in all health monitoring programs.

In conclusion, we have developed a semi-nested RT-PCR assay, and have shown this to be an useful method allowing us to detect NoV in fecal samples from laboratory rats.
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